Research Group
Nutritional Science
Sponsor
University of Arizona
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT01391689
This phase II/III trial studies how well diindolylmethane (DIM) works and compares it to placebo in treating patients with breast cancer. DIM may slow the growth of tumor cells and be an effective treatment for breast cancer.
Intervention
diindolylmethane, placebo
Condition
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
Investigators
Cynthia Thomson